Analysts’ Recent Ratings Changes for Calian Group (CGY)

Several analysts have recently updated their ratings and price targets for Calian Group (TSE: CGY):

• 8/14/2026 – Calian Group had its price target raised by Desjardins from C$104.00 to C$109.00. They now have a “buy” rating on the stock.
• 8/14/2026 – Calian Group had its price target raised by Ventum Financial from C$100.00 to C$106.00. They now have a “buy” rating on the stock.
• 8/14/2026 – Calian Group had its price target raised by Royal Bank Of Canada from C$90.00 to C$105.00. They now have an “outperform” rating on the stock.
• 8/14/2026 – Calian Group had its price target raised by Canadian Imperial Bank of Commerce from C$93.00 to C$107.00.
• 6/29/2026 – Calian Group had its price target raised by Canaccord Genuity Group Inc. from C$103.00 to C$105.00. They now have a “buy” rating on the stock.

Calian Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 9th. Investors of record on Wednesday, September 9th will be issued a $0.28 dividend. The ex-dividend date of this dividend is Wednesday, August 26th. This represents a $1.12 dividend on an annualized basis and a yield of 1.5%. Calian Group’s dividend payout ratio is presently 33.94%.

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.